Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal distention
abdominal tenderness
acetaminophen
adverse drug reaction
algorithm
amaurosis fugax
anasarca
andexanet
anemia
aneurysm, intracranial
anorexia
anterocollis
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation clinic
antiphospholipid antibodies
antiphospholipid antibody syndrome
aspirin
aspirin, dose of
atrial enlargement
atrial fibrillation
atrial fibrillation, nonvalvular
atrial fibrillation, risk stratification
atrial flutter
atrial septal defect
basilar artery stenosis
blood pressure
blood pressure after stroke
blood pressure, control
blood pressure, lowering
bridge therapy
cardiomyopathy
carotid artery occlusion, perioperative
carotid artery stenosis
carotid artery stenosis, intracranial
CAT scan
CAT scan, abnormal
cerebral atherosclerosis
cerebral embolism
cerebral embolism, cardiac origin
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cost of
cerebrovascular accident, etiology
cerebrovascular accident, multiple causes, coexisting
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, young adult
CHADS-VaSC score
chest x-ray
ciraparantag
cirrhosis
Clinical Pathologic Conference(C.P.C.)
clopidogrel
coagumeter
complications
confusion
controversies in neurology
coronary artery disease
cost effectiveness
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
critical pathway
cryptococcal meningoencephalitis
cryptococcosis
dabigatran
dabigatran, dose
dental procedure, neurologic complications with
diet
dipyridamole
disability, neurological
door to needle time
drug interactions
echocardiogram
echocardiogram, transesophageal
echocardiogram, transthoracic, false negative
efficacy
embolism
emergencies, neurologic
emergency room
encephalopathy
epidemiology of neurology
ESPRIT
factor Xa inhibitor
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, timing of administration
fiddleheads
fresh frozen plasma
fungal infection, CNS
gastrointestinal bleeding
HAS-BLED score
headache
headache, progressive
headache, severe
heart valve, prosthetic
heart valve, prosthetic, bioprosthetic
heart valve, prosthetic, mechanical
heart valve, prosthetic, thrombosis
hematuria, gross
hemorrhagic diathesis
hemostatic therapy
heparin
hepatic encephalopathy
hypertension
iatrogenic neurologic disorders
idarucizumab
immunosuppression
INR value, time in range
INR values
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, progression of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure, increased
invasive procedure
jaundice
laboratory values, normal
lacunar infarction
left atrial appendage
leuko-araiosis
level of consciousness, decreased
liver disease
lumbar puncture, repeated
meningoencephalitis
microhemorrhage, intracerebral
middle cerebral artery, stenosis of
mortality
MRI
MRI, abnormal
MRI, diffusion weighted
MRI, gradient-echo
MRI, perfusion
MRI, sulcal hyperintensity
myocardial infarction
myocardial infarction, acute
nausea and vomiting
neurologic complications of, surgery
neurologic practice
NIH stroke scale
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
old age, neurology of
pacemaker, cardiac-transvenous
pain, abdominal
patent foramen ovale, surgical treatment of
patient information and support
PFA-100
photophobia
platelet function test
platelet inhibiting drugs
platelet inhibiting drugs, discontinuation
pleocytosis of cerebrospinal fluid
point of care
postoperative neurologic complications
practice guidelines
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
protocol violations
quality of life
RELY trial
review article
risk factors
risk-benefit assessment
safety
Schwartz-Jampel syndrome
serologic testing
shock, cardiogenic
small vessel disease
stent, coronary artery
stool, guaiac positive
stroke protocol
thrombin inhibitor
thrombophlebitis
thrombophlebitis, prophylaxis
thrombus, mural
time is brain
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, coronary artery
treatment of neurologic disorder
venous thrombosis, non-cerebral
vertebral artery stenosis
vision, blurred
vision, blurred, monocular
vitamin K
vitamin K antagonist
WASID trial
weight loss
ximelagatran
Showing articles 50 to 64 of 64 << Previous

Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997

Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996

An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996

Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996

Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996

Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
NEJM 333:11-17, 541995., Cannegieter,S.C.,et al, 1995

US National Survey of Physician Practices for the Secondary & Tertiary Prevention of Ischemic Stroke:Common Practices
Stroke 26:1607-1615, Goldstein,L.B.,et al, 1995

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995

Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995

Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993

Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993

Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993

Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993



Showing articles 50 to 64 of 64 << Previous